1. Home
  2. SACH vs YI Comparison

SACH vs YI Comparison

Compare SACH & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$0.95

Market Cap

57.5M

Sector

Real Estate

ML Signal

HOLD

Logo 111 Inc.

YI

111 Inc.

HOLD

Current Price

$4.13

Market Cap

46.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SACH
YI
Founded
2010
2010
Country
United States
China
Employees
27
N/A
Industry
Real Estate Investment Trusts
Retail-Drug Stores and Proprietary Stores
Sector
Real Estate
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
57.5M
46.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SACH
YI
Price
$0.95
$4.13
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
251.6K
34.6K
Earning Date
05-06-2026
04-09-2026
Dividend Yield
19.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$145.00
N/A
Revenue Next Year
$6.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$2.48
52 Week High
$1.45
$11.17

Technical Indicators

Market Signals
Indicator
SACH
YI
Relative Strength Index (RSI) 41.47 41.12
Support Level $0.91 $3.39
Resistance Level $1.12 $4.88
Average True Range (ATR) 0.03 0.47
MACD 0.00 0.05
Stochastic Oscillator 31.65 37.50

Price Performance

Historical Comparison
SACH
YI

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: